Phosphodiesterase Type 5 Expression in Human and Rat Lower Urinary Tract Tissues and the Effect of Tadalafil on Prostate Gland Oxygenation in Spontaneously Hypertensive Rats
- 1 October 2011
- journal article
- Published by Oxford University Press (OUP) in The Journal of Sexual Medicine
- Vol. 8 (10) , 2746-2760
Abstract
Introduction In humans, prostate phosphodiesterase type 5 inhibitors (PDE5) expression was prominently localized in the endothelial and smooth muscle cells of the vascular bed, suggesting a possible action of PDE5 inhibitors (PDE5i) on prostate blood flow. Aim To investigate PDE5 expression in human and rat lower urinary tract (LUT) tissues, including vasculature, and determine the effects of PDE5 inhibition with tadalafil on prostatic blood perfusion. Main Outcome Measures Human vesicular‐deferential arteries (which originate from the inferior vesical artery, the main arterial source of blood supply to the bladder and prostate) were analyzed for PDE5 expression and activity. The effects of tadalafil on prostate oxygenation were studied in spontaneously hypertensive rats (SHR), characterized by ischemia/hypoxia of the genitourinary tract. Methods PDE5 expression was evaluated by quantitative reverse transcription‐polymerase chain reaction and immunohistochemistry. SHR were treated with tadalafil (2 mg/kg/day) for 1, 7, or 28 days and compared with untreated SHR and the unaffected counterpart Wistar‐Kyoto (WKY) rats. Prostate oxygenation was detected by Hypoxyprobe‐1 and hypoxia markers (hypoxia‐inducible factor‐1α[HIF‐1α] and endothelin‐1 type B [ETB]) immunostaining. Results Human vesicular‐deferential artery expressed high levels of PDE5, similar to corpora cavernosa, immunolocalized in the endothelial and smooth muscle layer. In these arteries, tadalafil inhibited cyclic guanosine monophosphate breakdown (half maximal inhibitory concentration (IC50) in the low nanomolar range, as in corpora cavernosa) and increased the relaxant response to sodium nitroprusside. SHR prostate resulted markedly hypoxic (hypoxyprobe immunopositivity) and positive for HIF‐1α and ETB, while tadalafil treatment restored oxygenation to WKY level at each time point. The mRNA expression of the HIF‐1α target gene, BCL2/adenovirus E1B 19 kDa interacting protein 3, was significantly increased in SHR prostate and partially restored to WKY level by tadalafil. Conclusion Human vesicular‐deferential artery is characterized by a high expression and activity of PDE5, which was inhibited by tadalafil in vitro. In SHR, tadalafil increases prostate tissue oxygenation, thus suggesting a possible mechanism through which PDE5i exert beneficial effects on LUT symptoms. Morelli A, Sarchielli E, Comeglio P, Filippi S, Mancina R, Gacci M, Vignozzi L, Carini M, Vannelli GB, and Maggi M. Phosphodiesterase type 5 expression in human and rat lower urinary tract tissues and the effect of tadalafil on prostate gland oxygenation in spontaneously hypertensive rats. J Sex Med 2011;8:2746–2760.Keywords
This publication has 53 references indexed in Scilit:
- Tadalafil administered once daily for lower urinary tract symptoms secondary to benign prostatic hyperplasia: a 1‐year, open‐label extension studyBJU International, 2011
- Vardenafil Modulates Bladder Contractility Through cGMP-mediated Inhibition of RhoA/Rho Kinase Signaling Pathway in Spontaneously Hypertensive RatsThe Journal of Sexual Medicine, 2009
- Differential Effects of Prazosin and Naftopidil on Pelvic Blood Flow and Nitric Oxide Synthase Levels in Spontaneously Hypertensive RatsJournal of Receptors and Signal Transduction, 2008
- Effects of doxazosin on blood flow and mRNA expression of nitric oxide synthase in the spontaneously hypertensive rat genitourinary tractLife Sciences, 2007
- Update on Phosphodiesterase (PDE) Isoenzymes as Pharmacologic Targets in Urology: Present and FutureEuropean Urology, 2006
- Pre‐clinical evidence for the use of phosphodiesterase‐5 inhibitors for treating benign prostatic hyperplasia and lower urinary tract symptomsBJU International, 2006
- Atherosclerosis as a risk factor for benign prostatic hyperplasiaBJU International, 2006
- Phosphodiesterase 5 in the female pig and human urethra: morphological and functional aspectsBJU International, 2006
- Protein kinase G‐induced activation of KATPchannels reduces contractility of human prostate tissueThe Prostate, 2005
- Vascular damage as a risk factor for benign prostatic hyperplasia and erectile dysfunctionBJU International, 2005